At a midpoint price of $299, thats ~750K scripts over three quarters, or ~250K per quarter
Alteration of gut microbiota by vancomycin and bacitracin improves insulin resistance via glucagonlike peptide 1 in dietinduced obesity
Association Between Insulin-like Growth Factor-1 rs35767 Polymorphism and Type 2 Diabetes Mellitus Susceptibility: A Meta-Analysis
Their core analytic tool is costeffectiveness analysis , typically quantifying health outcomes in quality-adjusted life years (QALYs) and comparing the incremental cost per QALY of a new drug against a threshold of willingness-to-pay (WTP) ( [17] ) ( [5] )
The information contained herein, including statistics, market updates, opportunities, risks, and recommendations regarding semaglutide (generic versions of Ozempic/Wegovy) and related GLP-1 drugs, is based on publicly available reports, studies, and news as of March 2026